Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Directory
Corporate Governance
Pipeline
Background - FAK
Background - Fibrotic Cancers
Background - Fibrosis
Our FAK Inhibitors
Investor Information
Welcome
Investor Fact Sheet
Current Presentations
Research Reports
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
>
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
ASX Announcements
Filter by Year:
2019
2018
29-Nov-2018
App 4D Half Year Accounts 30 Sep 2018
13-Nov-2018
Change of Director's Interest - Wilkinson - Options Expired
7-Nov-2018
Change of Director's Interest Notice - Andrew Cooke
30-Oct-2018
Appendix 4C - quarterly
5-Sep-2018
Amplia Investor Introduction
5-Sep-2018
Change of Name to Amplia Therapeutics Limited - ATX
4-Sep-2018
Change of Director's Interest - Cooke - Options
4-Sep-2018
Change of Director's Interest - Peach - Options
4-Sep-2018
Change of Director's Interest - Wilkinson - Options
4-Sep-2018
Appendix 3B - Options
1
